A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test, is now welcoming its first participants who will be recruited via memory clinics across the UK. The ADAPT (Alzheimer's Disease Diagnosis and Plasma pTau217) team, led by Professor Jonathan Schott and Dr Ashvini Keshavan (both UCL Queen Square Institute of Neurology) is investigating whether a blood test that measures the protein p-tau217 can improve the early and accurate